Mode
Text Size
Log in / Sign up
Phase 2 N=56 Randomized Double-blind Prevention

Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting

Coronary Artery Bypass Grafting · Cardiopulmonary Bypass · Reperfusion Injury

Enrolled (actual)
56
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcome: Primary: Left Ventricular Stroke Work Index (LVSWI) — 42; 43; 29; 28 g*m/m2

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Periostat (Drug); Placebo Oral Tablet (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Alberta
Primary completion
May 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Left Ventricular Stroke Work Index (LVSWI)
42; 43; 29; 28; 30; 29
SECONDARY
Cardiac Matrix Metalloproteinase-9 Activity in Right Atrial Biopsies at 10 Minutes Reperfusion
.75; 1.56; .44; 1.63
SECONDARY
Cardiac Matrix Metalloproteinase-2 Activity in Right Atrial Biopsies at 10 Minutes Reperfusion
.36; .24; .42; .25
SECONDARY
Venous Plasma Cardiac Matrix Metalloproteinase-9 Activity Before and After Reperfusion
.07; .11; .06; .12; 1.22; 1.37
SECONDARY
Venous Plasma Cardiac Matrix Metalloproteinase-2 Activity Before and After Reperfusion
.99; 1.06; .93; .96; 1.01; 1.05
SECONDARY
Venous Plasma Concentration of Troponin-I
1.23; 1.07; 1.39; 1.78
SECONDARY
Cleaved TroponinI/GAPDH Ratios in Right Atrial Biopsy
1.1318; 2.3454; 1.5195; 2.1893
SECONDARY
Venous Plasma Concentration of C-reactive Protein
5.7; 10; 5.7; 9.9; 4; 7.5
SECONDARY
Venous Plasma Concentration of IL-6
5.7; 1.9; 5.6; 2.8; 15.4; 7.3

Summary

The purpose of this study is to determine whether doxycycline (Periostat) at a sub-antimicrobial dose will decrease reperfusion injury after coronary artery bypass grafting (CABG) surgery with cardiopulmonary bypass (CPB).

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • Aged 18 through 80 years, inclusive
  • Scheduled for primary CABG surgery with CPB

Exclusion Criteria

  • Females of childbearing potential
  • Emergency CABG
  • Previous sternotomy
  • Planned simultaneous surgery (i.e. valve repair or carotid endarterectomy)
  • Myocardial infarction within 48 hours
  • Pre-operative atrial fibrillation
  • Pre-operative ventricular pacing or left bundle branch block (LBBB)
  • Known hypersensitivity to tetracycline class antibiotics
  • Renal failure requiring dialysis
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00246740). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search